Exact Mass: 321.96787340000003

Exact Mass Matches: 321.96787340000003

Found 72 metabolites which its exact mass value is equals to given mass value 321.96787340000003, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Chloramphenicol

D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenylethyl)acetamide

C11H12Cl2N2O5 (322.0123242)


An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01B - Amphenicols > J01BA - Amphenicols S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3070 C254 - Anti-Infective Agent > C258 - Antibiotic C784 - Protein Synthesis Inhibitor KEIO_ID C057; [MS3] KO008919 KEIO_ID C057; [MS2] KO008918 KEIO_ID C057

   

Minodronic acid

Minodronic acid

C9H12N2O7P2 (322.0119742)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2].

   

Dextramycin

2,2-Dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidate

C11H12Cl2N2O5 (322.0123242)


   

Minodronic acid

(1-Hydroxy-2-(imidazo(1,2-a)-pyridin-3-yl)ethylidene)bisphosphonic acid monohydrate

C9H12N2O7P2 (322.0119742)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2].

   

Trofosfamide

2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)-1,3,2lambda5-oxazaphosphinan-2-one

C9H18Cl3N2O2P (322.01714280000004)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens

   
   
   

chloramphenicol

2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide

C11H12Cl2N2O5 (322.0123242)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01B - Amphenicols > J01BA - Amphenicols S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic C784 - Protein Synthesis Inhibitor CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3461; ORIGINAL_PRECURSOR_SCAN_NO 3459 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3476; ORIGINAL_PRECURSOR_SCAN_NO 3473 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3449; ORIGINAL_PRECURSOR_SCAN_NO 3445 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3469; ORIGINAL_PRECURSOR_SCAN_NO 3467 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3457; ORIGINAL_PRECURSOR_SCAN_NO 3455 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3458; ORIGINAL_PRECURSOR_SCAN_NO 3457 Origin: Microbe, Propylene glycols, Nitrobenzenes CONFIDENCE standard compound; INTERNAL_ID 2306 CONFIDENCE standard compound; INTERNAL_ID 8318 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.577 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.575 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.573 CONFIDENCE standard compound; INTERNAL_ID 4073

   
   

2-[(4-bromo-1,3-thiazol-2-yl)methyl]isoindole-1,3-dione

2-[(4-bromo-1,3-thiazol-2-yl)methyl]isoindole-1,3-dione

C12H7BrN2O2S (321.9411582)


   

methyl 3-bromo-6-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

methyl 3-bromo-6-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

C10H6BrF3N2O2 (321.95647119999995)


   

N-BOC-2-AMINO-5-BROMOTHIAZOLE-4-CARBOXYLIC ACID

N-BOC-2-AMINO-5-BROMOTHIAZOLE-4-CARBOXYLIC ACID

C9H11BrN2O4S (321.9622866)


   

Ethanone,1,1-(oxydi-4,1-phenylene)bis[2-chloro-

Ethanone,1,1-(oxydi-4,1-phenylene)bis[2-chloro-

C16H12Cl2O3 (322.01634620000004)


   

1-bromo-4-(1,1,2,3,3,3-hexafluoropropoxy)benzene

1-bromo-4-(1,1,2,3,3,3-hexafluoropropoxy)benzene

C9H5BrF6O (321.9427932)


   

Benzene,2,3-bis(bromomethyl)-1,4-dimethoxy-

Benzene,2,3-bis(bromomethyl)-1,4-dimethoxy-

C10H12Br2O2 (321.92039719999997)


   
   

2-(5-BROMO-2-CHLORO-PHENYL)-BENZOOXAZOL-5-YLAMINE

2-(5-BROMO-2-CHLORO-PHENYL)-BENZOOXAZOL-5-YLAMINE

C13H8BrClN2O (321.9508488)


   

Methyl 4-acetoxy-6-bromo-2-naphthoate

Methyl 4-acetoxy-6-bromo-2-naphthoate

C14H11BrO4 (321.9840666)


   

3-(4-[(2,4-DICHLOROBENZYL)OXY]PHENYL)ACRYLIC ACID

3-(4-[(2,4-DICHLOROBENZYL)OXY]PHENYL)ACRYLIC ACID

C16H12Cl2O3 (322.01634620000004)


   
   

3-(4-((3,4-DICHLOROBENZYL)OXY)PHENYL)ACRYLIC ACID

3-(4-((3,4-DICHLOROBENZYL)OXY)PHENYL)ACRYLIC ACID

C16H12Cl2O3 (322.01634620000004)


   

4-CHLORO-3-((3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)OXY)ANILINE

4-CHLORO-3-((3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)OXY)ANILINE

C12H7Cl2F3N2O (321.9887508)


   

4-bromo-2-(3-hydroxypropyl)-6-(trifluoromethyl)benzimidazole

4-bromo-2-(3-hydroxypropyl)-6-(trifluoromethyl)benzimidazole

C11H10BrF3N2O (321.9928546)


   

2-Phospho-L-ascorbic acid trisodium salt

2-Phospho-L-ascorbic acid trisodium salt

C6H6Na3O9P (321.9442556000001)


L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) is a long-acting vitamin C derivative that can stimulate collagen formation and expression[1]. L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-Ascorbic acid 2-phosphate trisodium (2-Phospho-L-ascorbic acid trisodium) increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation[2][3].

   

4,4-CARBONYLBIS(PHTHALIC ANHYDRIDE)

4,4-CARBONYLBIS(PHTHALIC ANHYDRIDE)

C17H6O7 (322.0113526)


   
   
   

hexafluoroisopropyl tosylate

hexafluoroisopropyl tosylate

C10H8F6O3S (322.009833)


   
   

4-(4-Bromophenyl)dibenzo[b,d]furan

4-(4-Bromophenyl)dibenzo[b,d]furan

C18H11BrO (321.9993216)


   

4-iodo-1-[2-(oxan-2-yloxy)ethyl]pyrazole

4-iodo-1-[2-(oxan-2-yloxy)ethyl]pyrazole

C10H15IN2O2 (322.01782399999996)


   

1,2-bis(bromomethyl)-4,5-dimethoxybenzene

1,2-bis(bromomethyl)-4,5-dimethoxybenzene

C10H12Br2O2 (321.92039719999997)


   

3-CHLORO-4-{[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]OXY}ANILINE

3-CHLORO-4-{[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]OXY}ANILINE

C12H7Cl2F3N2O (321.9887508)


   

5-(Phenylsulfonyl)thiophene-2-sulfonyl chloride

5-(Phenylsulfonyl)thiophene-2-sulfonyl chloride

C10H7ClO4S3 (321.9195012)


   

3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)THIOPHENE-2-CARBOXYLIC ACID

3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)THIOPHENE-2-CARBOXYLIC ACID

C9H7ClN2O5S2 (321.9484922)


   

4-(iodomethyl)-9H-xanthene

4-(iodomethyl)-9H-xanthene

C14H11IO (321.9854626)


   

4-(benzenesulfonyl)thiophene-2-sulfonyl chloride

4-(benzenesulfonyl)thiophene-2-sulfonyl chloride

C10H7ClO4S3 (321.9195012)


   

2(4-BROMOPHENYL)-2,4,6-TRIHYDROXYACETOPHENONE

2(4-BROMOPHENYL)-2,4,6-TRIHYDROXYACETOPHENONE

C14H11BrO4 (321.9840666)


   

ETHANONE, 2-(4-IODOPHENYL)-1-PHENYL-

ETHANONE, 2-(4-IODOPHENYL)-1-PHENYL-

C14H11IO (321.9854626)


   
   

4,5-DICHLORO-2-(2,6-DICHLOROBENZYL)-2,3-DIHYDROPYRIDAZIN-3-ONE

4,5-DICHLORO-2-(2,6-DICHLOROBENZYL)-2,3-DIHYDROPYRIDAZIN-3-ONE

C11H6Cl4N2O (321.92342260000004)


   

2-bromo-1-(4-chlorophenyl)-2-(4-methylphenyl)ethanone

2-bromo-1-(4-chlorophenyl)-2-(4-methylphenyl)ethanone

C15H12BrClO (321.9759992)


   

Methyl 2-iodo-4,5-dimethoxybenzoate

Methyl 2-iodo-4,5-dimethoxybenzoate

C10H11IO4 (321.97020760000004)


   

Methyl 5-iodo-2,4-dimethoxybenzoate

Methyl 5-iodo-2,4-dimethoxybenzoate

C10H11IO4 (321.97020760000004)


   

2,4,6-tris(trifluoromethyl)-1H-benzimidazole

2,4,6-tris(trifluoromethyl)-1H-benzimidazole

C10H3F9N2 (322.0152506)


   

ETHYL 3-[5-(CHLOROSULFONYL)-2-THIENYL]-1,2,4-OXADIAZOLE-5-CARBOXYLATE

ETHYL 3-[5-(CHLOROSULFONYL)-2-THIENYL]-1,2,4-OXADIAZOLE-5-CARBOXYLATE

C9H7ClN2O5S2 (321.9484922)


   
   

5-Bromouridine

5-Bromouridine

C9H11BrN2O6 (321.9800446)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents 5-Bromouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

4-bromo-6-phenyldibenzo[b,d]furan

4-bromo-6-phenyldibenzo[b,d]furan

C18H11BrO (321.9993216)


   

N-(3,4-Dichlorophenyl)-P-methyl-N-(trifluoromethyl)phosphonamidic acid methyl ester

N-(3,4-Dichlorophenyl)-P-methyl-N-(trifluoromethyl)phosphonamidic acid methyl ester

C9H10Cl2F3NO2P (321.97782860000007)


   

2-(2-iodo-4,5-dimethoxy-phenyl)acetic acid

2-(2-iodo-4,5-dimethoxy-phenyl)acetic acid

C10H11IO4 (321.97020760000004)


   

5-[[(7-CHLORO-4-QUINOLINYL)SULFANYL]METHYL]-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

5-[[(7-CHLORO-4-QUINOLINYL)SULFANYL]METHYL]-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

C13H11ClN4S2 (322.0113636)


   

2-[(2-bromo-1,3-thiazol-5-yl)methyl]isoindole-1,3-dione

2-[(2-bromo-1,3-thiazol-5-yl)methyl]isoindole-1,3-dione

C12H7BrN2O2S (321.9411582)


   

2-Bromo-1-(1-pyrenyl)ethanone

2-Bromo-1-(1-pyrenyl)ethanone

C18H11BrO (321.9993216)


   

3-[(4-Bromophenyl)methoxy]-6-methyl-2-nitropyridine

3-[(4-Bromophenyl)methoxy]-6-methyl-2-nitropyridine

C13H11BrN2O3 (321.99529959999995)


   
   

5-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]-4-ethyl-4H-1,2,4-triazole-3-thiol

5-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]-4-ethyl-4H-1,2,4-triazole-3-thiol

C13H11ClN4S2 (322.0113636)


   

N,N-diethylcarbamodithioic acid (2,2,2-trichloro-1-formamidoethyl) ester

N,N-diethylcarbamodithioic acid (2,2,2-trichloro-1-formamidoethyl) ester

C8H13Cl3N2OS2 (321.9534858)


   
   

1,3-Bis(bromomethyl)-2,5-dimethoxybenzene

1,3-Bis(bromomethyl)-2,5-dimethoxybenzene

C10H12Br2O2 (321.92039719999997)


   

Trofosfamide

Trofosfamide

C9H18Cl3N2O2P (322.01714280000004)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens

   

p-Mercuribenzoate

p-Mercuribenzoate

C7H4HgO2- (321.9917604)


D010575 - Pesticides > D005659 - Fungicides, Industrial > D010663 - Phenylmercury Compounds D004791 - Enzyme Inhibitors > D008626 - Mercuribenzoates

   

4-chloro-N-(4-chloro-2,5-dimethoxyphenyl)-5-dithiazolimine

4-chloro-N-(4-chloro-2,5-dimethoxyphenyl)-5-dithiazolimine

C10H8Cl2N2O2S2 (321.94042479999996)


   

4-[(5-Bromo-8-quinolinyl)amino]-4-oxobutanoic acid

4-[(5-Bromo-8-quinolinyl)amino]-4-oxobutanoic acid

C13H11BrN2O3 (321.99529959999995)


   

(4-Hydroxy-5-iodo-3-nitrophenyl)acetate

(4-Hydroxy-5-iodo-3-nitrophenyl)acetate

C8H5INO5- (321.921249)


   

2,5,6-Trichloro-1-(beta-D-erythrofuranosyl)benzimidazole

2,5,6-Trichloro-1-(beta-D-erythrofuranosyl)benzimidazole

C11H9Cl3N2O3 (321.96787340000003)


   

2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide

2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide

C11H12Cl2N2O5 (322.0123242)


   

α-D-Glucose-1-phosphate (disodium hydrate)

α-D-Glucose-1-phosphate (disodium hydrate)

C6H13Na2O10P (322.00417280000005)


α-D-Glucose-1-phosphate disodium hydrate is used as a starting material for synthesis of glucuronic acid. α-D-Glucose-1-phosphate disodium hydrate can be used as a cytostatic compound essential for cardiopathic therapy, as an antibiotic, as an immunosuppressive agent, and as a circulatory system therapy element[1].

   

2-[(dichloromethoxy)methyl]-3-hydroxy-3-(4-nitrophenyl)propanimidic acid

2-[(dichloromethoxy)methyl]-3-hydroxy-3-(4-nitrophenyl)propanimidic acid

C11H12Cl2N2O5 (322.0123242)